Can recent-onset atrial fibrillation be safely and successfully treated with self-administered antiarrhythmic drugs?
Wyse
D George
DG
Cardiac Sciences, Medicine and Pharmacology and Therapeutics at the Libin Cardiovascular Institute of Alberta, University of Calgary and the Calgary Health Region, Calgary, Alberta, Canada. dgwyse@ucalgary.ca
D000293:Adolescent; D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000503:physiopathology; D004562:Electrocardiography; D005424:Flecainide / Q000008:administration & dosage*; D005500:Follow-Up Studies; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D011405:Propafenone / Q000008:administration & dosage*; D011446:Prospective Studies; D012646:Self Administration; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents; D011405:Propafenone; D005424:Flecainide